V

Voyager Therapeutics
D

VYGR

5.06000
USD
0.01
(0.20%)
مغلق
حجم التداول
3,261
الربح لكل سهم
-1
العائد الربحي
-
P/E
8
حجم السوق
276,405,465
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ALKS
    -0.270
    (-0.91%)
    29.480 USD
    A
    ARCT
    -0.240
    (-1.41%)
    16.760 USD
    B
    BLUE
    0.05000
    (0.60%)
    8.35000 USD
    C
    CLLS
    -0.03000
    (-1.98%)
    1.48500 USD
    C
    CRSP
    0.260
    (0.65%)
    40.520 USD
    E
    EDIT
    -0.03000
    (-2.40%)
    1.22000 USD
    N
    NTLA
    0.09000
    (0.96%)
    9.50000 USD
    Q
    QURE
    -0.190
    (-1.33%)
    14.050 USD
    S
    SGMO
    -0.00500
    (-0.45%)
    1.10000 USD
    المزيد
الأخبار
المقالات

العنوان: Voyager Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.